Broadwood increases STAAR Surgical (STAA) stake with January share buys

Rhea-AI Filing Summary

Broadwood Partners, L.P., a 10% owner of STAAR Surgical Co. (STAA), reported open‑market purchases of the company’s common stock in early January 2026. Broadwood Partners bought 186,946 shares at a weighted average price of $21.0111 and 150,000 shares at $22.3756 on January 6, followed by 66,467 shares at $22.0004 on January 7 and 3,240 shares at $21.9389 on January 8. After these transactions, Broadwood Partners reported holding 15,426,144 shares of STAAR Surgical common stock. A separate holding of 25,900 STAAR Surgical shares is reported as being directly owned by Neal C. Bradsher. The filing notes that Broadwood Capital, Inc. and Neal C. Bradsher may be deemed indirect beneficial owners through their roles with Broadwood Partners, but each disclaims beneficial ownership except to the extent of any pecuniary interest.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BROADWOOD PARTNERS, L.P.

(Last) (First) (Middle)

C/O BROADWOOD CAPITAL, INC.

156 WEST 56TH STREET, 3RD FLOOR

(Street)

NEW YORK NY 10019

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
STAAR SURGICAL CO [ STAA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/06/2026		P		186,946	A	$21.0111(2)	15,206,437	D(1)
Common Stock	01/06/2026		P		0	A	$0	15,206,437	I	Footnote(1)
Common Stock	01/06/2026		P		150,000	A	$22.3756(3)	15,356,437	D(1)
Common Stock	01/06/2026		P		0	A	$0	15,356,437	I	Footnote(1)
Common Stock	01/07/2026		P		66,467	A	$22.0004(4)	15,422,904	D(1)
Common Stock	01/07/2026		P		0	A	$0	15,422,904	I	Footnote(1)
Common Stock	01/08/2026		P		3,240	A	$21.9389(5)	15,426,144	D(1)
Common Stock	01/08/2026		P		0	A	$0	15,426,144	I	Footnote(1)
Common Stock								25,900	D(6)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

BROADWOOD PARTNERS, L.P.

(Last) (First) (Middle)

C/O BROADWOOD CAPITAL, INC.

156 WEST 56TH STREET, 3RD FLOOR

(Street)

NEW YORK NY 10019

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

BROADWOOD CAPITAL INC

(Last) (First) (Middle)

156 WEST 56TH STREET, 3RD FLOOR

(Street)

NEW YORK NY 10019

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Bradsher Neal C

(Last) (First) (Middle)

C/O BROADWOOD CAPITAL, INC.

156 WEST 56TH STREET, 3RD FLOOR

(Street)

NEW YORK NY 10019

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed to be indirectly beneficially owned by: (i) Broadwood Capital, Inc. ("Broadwood Capital") as General Partner of Broadwood Partners; and (ii) Neal C. Bradsher as President of Broadwood Capital. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

2. This constitutes the weighted average purchase price. The prices range from $20.92 to $21.09. The Reporting Person will provide upon request by the Securities and Exchange Commission staff (the "SEC Staff"), the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

3. This constitutes the weighted average purchase price. The prices range from $21.97 to $22.58. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

4. This constitutes the weighted average purchase price. The prices range from $21.81 to $22.09. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

5. This constitutes the weighted average purchase price. The prices range from $21.86 to $21.97. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

6. These securities are directly owned by Neal C. Bradsher.

	Broadwood Partners, L.P., By: Broadwood Capital, Inc., By: /s/ Neal C. Bradsher, President	01/08/2026
	Broadwood Capital, Inc., By: /s/ Neal C. Bradsher, President	01/08/2026
	Neal C. Bradsher, /s/ Neal C. Bradsher	01/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did STAA report in this Form 4 filing?

The Form 4 reports that Broadwood Partners, L.P., a 10% owner of STAAR Surgical Co., purchased additional shares of STAAR Surgical common stock in open‑market transactions on January 6–8, 2026, increasing its reported holdings.

How many STAAR Surgical (STAA) shares does Broadwood Partners now report owning?

After the reported January 2026 purchases, Broadwood Partners, L.P. reports beneficial ownership of 15,426,144 shares of STAAR Surgical common stock.

At what prices did Broadwood Partners buy STAAR Surgical shares in January 2026?

Broadwood Partners’ reported weighted average purchase prices were $21.0111 and $22.3756 on January 6, 2026, $22.0004 on January 7, 2026, and $21.9389 on January 8, 2026.

Who are the reporting persons in this STAAR Surgical (STAA) Form 4?

The reporting persons are Broadwood Partners, L.P., Broadwood Capital, Inc., and Neal C. Bradsher. Broadwood Partners directly owns the reported block of shares, while Broadwood Capital and Neal C. Bradsher are listed due to their roles with Broadwood Partners.

Does Neal C. Bradsher personally own STAAR Surgical shares?

Yes. A footnote states that 25,900 STAAR Surgical common shares are directly owned by Neal C. Bradsher, separate from the larger position reported as directly owned by Broadwood Partners, L.P..

How do Broadwood Capital and Neal C. Bradsher describe their beneficial ownership of STAA shares?

The filing explains that the reported securities are directly owned by Broadwood Partners, L.P. and may be deemed indirectly beneficially owned by Broadwood Capital, Inc. and Neal C. Bradsher, but each reporting person disclaims beneficial ownership except to the extent of its or his pecuniary interest.